FDA's Internet Promotion Policy: Christmas Cards In Lieu Of Guidance?
Executive Summary
Industry will ring in the New Year with no more guidance from FDA on Internet and social media promotion than the warning and untitled letters that FDA has issued during the past several years.
You may also be interested in...
FDA’s Social Media Guidance: As Industry Waits, How Watchful Should It Be?
In the absence of clear policy from the agency, GSK keeps careful eyes on Facebook, but experts disagree on the extent to which drug companies are required to actively monitor social media sites.
DTC Pre-Review Guidance In The Works For Rx TV Ads, FDA’s Abrams Says
Certain drug classes will be required to submit certain types of ads, according to Tom Abrams, director of CDER’s recently elevated Office of Prescription Drug Promotion, but specifics will await the guidance itself.
Pfizer's "Online Resources" Are Over The Line For FDA
Reintegrating the principles in its seminal citations of search engine ads, DDMAC tells Pfizer to stop including "riskless" links for named drugs as part of its Lipitor website.